LON:ZAIM Adalan Ventures (ZAIM) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Adalan Ventures Stock (LON:ZAIM) Get Adalan Ventures alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume100 shsAverage Volume537,065 shsMarket Capitalization£2.31 millionP/E Ratio120.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Adalan Ventures Plc provides microloans to individuals. The company was formerly known as Zaim Credit Systems Plc and changed its name to Adalan Ventures Plc in May 2023. The company was founded in 2011 and is headquartered in London, the United Kingdom. Read More Receive ZAIM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Adalan Ventures and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ZAIM Stock News HeadlinesAdalan Ventures Wins Full Shareholder Backing at 2026 AGMJune 9, 2026 | tipranks.comAdalan Ventures Sets June Date and Proxy Timetable for AGMMay 15, 2026 | tipranks.comNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to its existing Orphan Drug Designation and opening a path toward a Priority Review Voucher, assets that have recently sold for around 195 million dollars. Noble Capital Markets initiated coverage with an Outperform rating and a 6 dollar price target, citing NNVC's broad-spectrum nanoviricide technology and its potential across Measles, MPox, Smallpox, and Ebola, where a Phase II trial is advancing in the Democratic Republic of Congo.September 16 at 1:00 AM | Equiscreen (Ad)Adalan Ventures’ 2025 Audit Flags Funding Strain and Going-Concern RisksApril 30, 2026 | tipranks.comAdalan Ventures Reshapes Board Ahead of Planned Topos Reverse TakeoverMarch 3, 2026 | tipranks.comAdalan Ventures Shareholders Approve All AGM ResolutionsJanuary 29, 2026 | tipranks.comAdalan Ventures’ 2024 Audit Flags Going-Concern Risks Amid Funding NeedsDecember 29, 2025 | tipranks.comAdalan Ventures Plc to Update Articles of Association for FCA ComplianceJuly 17, 2025 | tipranks.comSee More Headlines ZAIM Stock Analysis - Frequently Asked Questions How were Adalan Ventures' earnings last quarter? Adalan Ventures Plc (LON:ZAIM) issued its quarterly earnings results on Tuesday, May, 5th. The company reported ($0.88) earnings per share for the quarter. How do I buy shares of Adalan Ventures? Shares of ZAIM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Company Calendar Last Earnings5/05/2026Today9/16/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorFinance Industry Consumer Finance Sub-IndustryConsumer Finance Current SymbolLON:ZAIM CIKN/A Webwww.zaimcreditsystemsplc.com Phone44 2031 371 902FaxN/AEmployees128Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio120.00 Forward P/E RatioN/A P/E GrowthN/ANet Income-£10.92 million Net MarginsN/A Pretax MarginN/A Return on Equity-1,160.74% Return on Assets-406.13% Debt Debt-to-Equity Ratio52.00 Current Ratio0.09 Quick Ratio3.60 Sales & Book Value Annual Sales£4.94 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow5.00 Book ValueGBX (1) per share Price / BookN/AMiscellaneous Outstanding Shares51,350,000Free FloatN/AMarket Cap£2.31 million OptionableNot Optionable Beta0.13 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (LON:ZAIM) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our Partners“This is the Perfect Tech Stock”Jeff Brown, the tech investor who identified Nvidia in 2016 before its 37,000% run, has flagged a new AI compa...Brownstone Research | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredThis Gold Explorer Is Approaching Its Biggest Milestone YetA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...Equiscreen | SponsoredJon Najarian's #1 Energy Trade for 2026Jon Najarian says he's never been more excited about an energy opportunity. SpaceX just went public at over $2...Banyan Hill Publishing | SponsoredMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...Paradigm Press | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adalan Ventures Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Adalan Ventures With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZAIM Stock Alerts